(Q44673128)

English

Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Gemcitabine plus vinorelbine chemotherapy in patients with advanced bladder carcinoma who are medically unsuitable for or who have failed cisplatin-based chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

bladder carcinoma

1 reference

based on heuristic

inferred from title

author name string

Kadir Türkölmez

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yaşar Bedük

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sümer Baltaci

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Cağatay Göğüş

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Orhan Göğüş

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 December 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

European Urology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

682-686

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Progress in the chemotherapy of metastatic cancer of the urinary tract

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Weekly gemcitabine in advanced bladder cancer: a preliminary report from a phase I study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility trial of a combination of vinorelbine, ifosfamide, fluorouracil and folinic acid (VIF regimen) in advanced urothelial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine).

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinum. Italian Co-operative Group on Bladder Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is gemcitabine plus vinorelbine active in second-line chemotherapy of metastatic breast cancer? a single-center phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination Chemotherapy with Gemcitabine and Vinorelbine in the Treatment of Patients with Relapsed or Refractory Small Cell Lung Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Carboplatin, methotrexate, and vinblastine in patients with bladder cancer who were ineligible for cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel plus carboplatin in advanced carcinoma of the urothelium: an active and tolerable outpatient regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and ifosfamide as second line treatment for patients with advanced or metastatic urothelial cancer after failure of platinum chemotherapy: a phase 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900385-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0302-2838(03)00385-3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44673128&oldid=2031303198"